Referenzen
- Actelion Pharmaceuticals Ltd., Switzerland
- Beiersdorf AG, Hamburg, Germany
- Bruker Daltonik GmbH, Bremen, Germany
- Cytoguide ApS, Arhus, Denmark
- Danisco A / S, Copenhagen, Denmark
- ETH Zürich, Switzerland
- Helm AG, Hamburg, Germany
- Humboldt-Universität, Berlin, Germany
- ISM Therapeutics, Seattle, USA
- Johnson&Johnson Pharmaceutical R&D Division, Beerse, Belgium
- National Institute of Health (NIH), Bethesda, USA
- Nederlands Kanker Instituut (NKI), Amsterdam, Netherlands
- Novartis Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland
- Novartis Institute for Functional Genomics (NIFG), San Diego, USA
- TAVARGENIX GmbH, Darmstadt, Germany
- The Babraham Institute, Cambridge, UK
- Universitätsklinikum Düsseldorf, Germany
- Universitätsklinikum Eppendorf (UKE), Hamburg, Germany
- University of Bern, Switzerland
- University of California, Irvine, USA
- Weill Cornell Medical College, Qatar
- European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
- Nycomed GmbH, Konstanz, Germany
- DAX-listed company (chemical sector), Germany
- Nasdaq100-listed company (pharmaceutical sector), Israel
